Back
Fulcrum Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
71
FULC
Fulcrum Therapeutics
Last Price:
$7.39
Seasonality Move:
23.37%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing slight selling pressure.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.18 | Buy |
| 20-day SMA: | 7.01 | Buy |
| 50-day SMA: | 6.42 | Buy |
| 200-day SMA: | 4.3 | Buy |
| 8-day EMA: | 3.11 | Buy |
| 20-day EMA: | 1.43 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 0.16 | Buy |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 69.95 | Buy |
| Chaikin Money Flow: | -117223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.7 - 7.36) | Buy |
| Bollinger Bands (100): | (3.03 - 6.57) | Buy |
Fulcrum Therapeutics Technical Analysis
| Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 7.91 while FULC 8-day simple moving average is 7.18, which is a Buy signal.
-
The stock price of FULC is 7.91 while Fulcrum Therapeutics 20-day SMA is 7.01, which makes it a Buy.
-
Fulcrum Therapeutics 50-day simple moving average is 6.42 while FULC share price is 7.91, making it a Buy technically.
-
FULC stock price is 7.91 and Fulcrum Therapeutics 200-day simple moving average is 4.30, creating a Buy signal.
FULC Technical Analysis vs Fundamental Analysis
Buy
71
Fulcrum Therapeutics (FULC)
is a Buy
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a BuyThe current Fulcrum Therapeutics [FULC] share price is $7.91. The Score for FULC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
427M
Price in USD:
7.91
Share Volume:
937.8K
Fulcrum Therapeutics 52-Week Range
52-Week High:
10.13
52-Week Low:
2.32
Buy
71
Fulcrum Therapeutics (FULC)
is a Buy
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?The Fulcrum Therapeutics stock price is 7.91 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is not overvalued.
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 7.91 while FULC 8-day exponential moving average is 3.11, which is a Buy signal.
-
The stock price of FULC is 7.91 while Fulcrum Therapeutics 20-day EMA is 1.43, which makes it a Buy.
-
Fulcrum Therapeutics 50-day exponential moving average is 0.61 while FULC share price is 7.91, making it a Buy technically.
-
FULC stock price is 7.91 and Fulcrum Therapeutics 200-day simple moving average is 0.16, creating a Buy signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.02 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is 1.11, suggesting Fulcrum Therapeutics is a Buy
-
Fulcrum Therapeutics Relative Strength Index (RSI) is 69.95, which suggest Fulcrum Therapeutics is overbought
-
The Bollinger Bands (25) for Fulcrum Therapeutics is (6.7 - 7.36), which suggest Fulcrum Therapeutics is a Buy
-
The Bollinger Bands (100) for Fulcrum Therapeutics is (3.03 - 6.57), which suggest Fulcrum Therapeutics is a Buy
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.